Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines
- 21 February 2009
- journal article
- Published by Elsevier in Human Immunology
- Vol. 70 (5) , 281-288
- https://doi.org/10.1016/j.humimm.2009.02.004
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Yellow fever vaccine induces integrated multilineage and polyfunctional immune responsesThe Journal of Experimental Medicine, 2008
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic CellsImmunity, 2008
- Identification of a novel population of Langerin+ dendritic cellsThe Journal of Experimental Medicine, 2007
- Blood-derived dermal langerin+ dendritic cells survey the skin in the steady stateThe Journal of Experimental Medicine, 2007
- The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cellsThe Journal of Experimental Medicine, 2007
- Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15Immunity, 2007
- Plasmacytoid dendritic cell–specific receptor ILT7–FcεRIγ inhibits Toll-like receptor–induced interferon productionThe Journal of Experimental Medicine, 2006
- Langerhans cells cross-present antigen derived from skinProceedings of the National Academy of Sciences, 2006
- Skin-Derived Dendritic Cells Induce Potent CD8+ T Cell Immunity in Recombinant Lentivector-Mediated Genetic ImmunizationImmunity, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006